Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis.
Saved in:
| Title: | Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis. |
|---|---|
| Authors: | Furlan R; Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS Ospedale San Raffaele, and Vita e Salute San Raffaele University, Milan 20132, Italy., Schaedelin S; Department of Clinical Research, University Hospital Basel, University of Basel, Basel 4031, Switzerland., Frederiksen JL; Department of Neurology at Rigshospitalet and Institute of Clinical Medicine, University of Copenhagen, Copenhagen 2100, Denmark., Watanabe M; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan., Isobe N; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan., Piehl F; Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Fink K; Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Iacobaeus E; Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Evertsson B; Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Khademi M; Department of Clinical Neuroscience, Karolinska Institutet and Department of Neurology, Karolinska University Hospital, Stockholm SE-171 76, Sweden., Gastaldi M; Multiple Sclerosis Center, IRCCS Mondino Foundation, and Department of Brain and Behavioural Sciences, University of Pavia, Pavia 27100, Italy., Greco G; Multiple Sclerosis Center, IRCCS Mondino Foundation, and Department of Brain and Behavioural Sciences, University of Pavia, Pavia 27100, Italy., Mariotto S; Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy., Carta S; Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona 37134, Italy., Di Sapio A; Department of Neurology, Regional Referral MS Center and CRESM BioBank, San Luigi Gonzaga University Hospital, Orbassano 10043, Italy., Bava CI; Department of Neurology, Regional Referral MS Center and CRESM BioBank, San Luigi Gonzaga University Hospital, Orbassano 10043, Italy., Giorgi L; Department of Neurology, Regional Referral MS Center and CRESM BioBank, San Luigi Gonzaga University Hospital, Orbassano 10043, Italy., Benkert P; Department of Clinical Research, University Hospital Basel, University of Basel, Basel 4031, Switzerland., Maceski AM; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland., Oechtering J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland., Willemse E; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland., Pröbstel AK; Center of Neurology, Department of Neuroimmunology, University Hospital and University Bonn, Bonn 53127, Germany., Pretzsch R; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland., Finardi A; Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS Ospedale San Raffaele, and Vita e Salute San Raffaele University, Milan 20132, Italy., Mandelli A; Clinical Neuroimmunology Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS Ospedale San Raffaele, and Vita e Salute San Raffaele University, Milan 20132, Italy., Anthony DC; Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK., Kuhle J; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland., Leppert D; Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, and Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland. |
| Source: | Brain : a journal of neurology [Brain] 2026 Apr 07; Vol. 149 (4), pp. 1319-1331. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
